Dugos, Baby Girl .

HRN: 22-87-61  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/18/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
04/18/2023
04/24/2023
IVT
300mg
Q12
Neonatal Sepsis
Waiting Final Action 

Indication:  Empirical Escalation    Type of Infection:  PneumoniaBloodstream    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: